Examination of blood samples from patients with CM have identified the upregulation of soluble levels of adhesion molecules, including intercellular adhesion molecule-1 (ICAM-1), and the dysregulation of endothelial surface markers as risk factors for complications associated with CM [13, 14]. The gene discussed is ICAM1; the disease is cutaneous mastocytosis.